Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 3 Secondary outcomes in the MP group and DXM group

From: A comparative study between methylprednisolone versus dexamethasone as an initial anti-inflammatory treatment of moderate COVID-19 pneumonia: an open-label randomized controlled trial

Secondary outcomes

MP group (n = 25)

DXM group (n = 25)

p-value

Day 5 PaO2/FiO2ratio; mean ± S.D.

355.6 ± 79.1

338.9 ± 82.9

0.474

 Hypoxemia PaO2/FiO2 ratio > 300

75%

64%

 

  PaO2/FiO2 ratio > 200–300

16.7%

32%

 

  PaO2/FiO2 ratio 100–200

8.3%

4%

0.478

Day 10 PaO2/FiO2ratio; mean ± S.D.

369.0 ± 77.7

388.6 ± 72.3

0.370

 Hypoxemia PaO2/FiO2 ratio > 300

75%

83.3%

 

 PaO2/FiO2 ratio > 200–300

25%

16.7%

0.477

Day 5 CRP(mg/L); median (IQR)

7.2 (5.4–17.8)

7.8 (5.5–24.3)

0.667

 Normalized CRP < 10 mg/dl

13 (54.2%)

13 (52%)

0.879

Day 10 CRP; median (IQR)

6 (2.9–13.7)

6 (3.4–18.0)

0.844

 Normalized CRP < 10 mg/dl

16 (66.7%)

14 (58.3%)

0.551

Day 5 LDH(IU/L); mean ± S.D.

264 ± 87.3

240.4 ± 95.7

0.368

Day 10 LDH; mean ± S.D.

254.9 ± 91.8

237.2 ± 82.0

0.484

Day 5 SOFA score; median (IQR)

1 (1-2.5)

1 (1–2)

0.883

Day 10 SOFA score; median (IQR)

1 (0.5-2)

0 (0–2)

0.103

Day 5 D-dimer(mcg/mL); median (IQR)

846.5 (470–2492)

1021 (474–1996)

0.976

Day 10 D-dimer; median (IQR)

1043 (594.5–1712)

1189 (576.5-3880.5)

0.446

Being alive with SaO2≥ 96% room air

Day 14

16 (64%)

18 (72%)

0.544

Day 28

21 (84%)

21 (84%)

1.000

Being alive without mechanical ventilation

 Day 14

23 (92%)

23 (92%)

1.000

 Day 28

22 (88%)

22 (88%)

1.000

Being alive without hospitalization

 Day 14

16 (64%)

18 (72%)

0.544

 Day 28

21 (84%)

20 (80%)

1.000

Transfer to intensive care unit

3 (12%)

3 (12%)

1.000

Acute respiratory failure

2 (8%)

2 (8%)

1.000

Length of hospitalization (days)

 Excluded hospital death; median (IQR)

13 (10–18)

11 (9–13)

0.227

Hospital mortality

2 (8%)

2 (8%)

1.000

28-day mortality

3 (12%)

2 (8%)

1.000

90-day mortality

4 (16%)

3 (12%)

1.000

  1. Data are presented as n (%), mean (standard deviation or S.D.) or median (interquartile range or IQR). MP: methylprednisolone; DXM: dexamethasone; PaO2: arterial oxygen tension; FiO2: inspiratory oxygen fraction; CRP: C-reactive protein; LDH: lactate dehydrogenase; SOFA score: Sequential organ failure assessment score; SaO2 : Oxygen saturation